Clinical Trials Browser

Hemangiosarcoma × Bevacizumab × Clear all

NCT01303497 2026-03-13

ANGIO-TAX+

Phase 2 Completed

Hemangiosarcoma

NCT00887809 2016-01-25

Gemcitabine and Docetaxel With Bevacizumab in Selected Sarcoma Subtypes

Phase 2 Completed

47 enrolled 7 charts

Hemangiosarcoma, Leiomyosarcoma, Sarcoma, Histiocytoma